title: [Lupus disease with antinuclear antibodies of the nucleolar type. Apropos of a series of 13 cases].
abstract: An exclusive or predominant nucleolar location of antinuclear antibodies is rare in the course of lupus disease: less than 1 p. cent of our patients. Thirteen cases of lupus disease with exclusive or predominant antinucleolar antibodies are analyzed: clinically, the only difference from other lupus diseases is the absence of pleurisy (p less than 0.03) and the frequent thrombopenia (p = 0.05). A proliferative glomerular lesion was found 4 times on renal biopsy. No patient presented any indications of overlapping sign with sclerodermia, polymyositis or Gougerot-Sjögren syndrome which are usually associated to a nuclear fluorescence of nucleolar type. 11 out of 13 patients have natural anti-DNA antibodies, including 9 with a very weak titer. Six patients present cytoplasmic anti-organic antibodies. Four patients have antibodies which precipitates on gelose, identifying nuclear or cytoplasmic antibodies: in 1 instance anti-SS-B et SS-A (Ro), in 1 instance anti-ribosomes associated with anti-ADN, in one instance anti-DNA. No serum contained anti-histones antibodies. The study of the sensitivity of nucleolar antigens to digestion by various enzymes (DNAse, RNAse and trypsin) showed that antinucleolar sera could be placed into three groups: 8/10 recognize a ribonucleic antigen, 1/10 a ribonucleoproteic antigen and 1/10 an antigen resisting to various enzymatic digestions. Therefore, in spite of its rarity, an exclusively nucleolar fluorescence should not rule out the diagnosis of lupus disease.
authors.affiliation: Clkinique Rhumatologique, Université Paris VII, Faculté de Médecine Lariboisière, Paris.
authors.forename: O
authors.initials: O
authors.lastname: Meyer
authors.forename: P
authors.initials: P
authors.lastname: Bourgeois
authors.forename: L
authors.initials: L
authors.lastname: Zakraoui
authors.forename: J C
authors.initials: JC
authors.lastname: Piette
authors.forename: J M
authors.initials: JM
authors.lastname: Ziza
authors.forename: O
authors.initials: O
authors.lastname: Blétry
authors.forename: M F
authors.initials: MF
authors.lastname: Kahn
authors.forename: P
authors.initials: P
authors.lastname: Godeau
authors.forename: A
authors.initials: A
authors.lastname: Ryckewaert
mesh_terms: D000293:Adolescent; D000328:Adult; D000486:Allergy and Immunology; D000974:Antibodies, Antinuclear / Q000032:analysis*; D002466:Cell Nucleolus / Q000276:immunology*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007158:Immunologic Techniques; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000276:immunology*; D008297:Male; D008875:Middle Aged
chemical_list: D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D007075:Immunoglobulin M
vernacular_title: Maladie lupique avec anticorps antinucléaires de type nucléolaire. A propos d'une série de 13 cas.